AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,549,322 | -25.7% | 371,540 | -7.5% | 0.12% | -10.5% |
| Q4 2021 | $2,083,993 | -20.1% | 401,540 | +0.9% | 0.13% | -26.5% |
| Q3 2021 | $2,607,385 | -17.0% | 398,074 | -15.9% | 0.18% | -13.4% |
| Q2 2021 | $3,141,211 | +126.7% | 473,074 | +205.2% | 0.21% | +28.2% |
| Q4 2020 | $1,385,530 | -66.5% | 154,981 | -40.0% | 0.16% | -71.3% |
| Q2 2020 | $4,141,511 | +229.2% | 258,360 | +23.0% | 0.57% | +81.5% |
| Q1 2020 | $1,257,978 | – | 210,013 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |